Evotec

Seattle-Based Pharma Co. Awarded $74MM DOD Contract for Drug Production

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that the U.S. Department of Defense (“DOD”) has awarded Evotec’s...